A continuous quality improvement approach helped identify and intervene in vascular access issues for patients on home ...
According to the latest market analysis by Future Market Insights, the global vascular endothelial growth factor inhibitor ...
Endothelial dysfunction is a hallmark of cardiovascular disease (CVD) and plays a central role in vascular inflammation, ...
A study published in Arteriosclerosis, Thrombosis, and Vascular Biology has identified Bmal1 as a potential key driver of ...
Vascular disease affects both arteries and veins, leading to serious conditions like heart attacks, strokes, and even limb loss. While it develops over time, early detection can make all the ...
Dr. Thomas Eskew, a vascular surgeon with Novant Health, was in the studio to discuss why vascular health is so impactful and ...
A new study led by researchers at UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has identified potential biological ...
In the first quarter of 2026, Conestoga Capital Advisors highlighted LeMaitre Vascular as a leading contributor, citing mid-teens revenue growth and a 47% increase in operating income driven by ...
Physicians at Baylor Medicine Vascular Health in Houston, Texas, provide a full spectrum of diagnostic evaluation and interventional treatment of problems with arterial and venous blood flow in the ...
Vascular dementia is damage in the brain that occurs due to reduced blood flow. People most often develop vascular dementia following a stroke, but there are several other potential causes and risk ...
Zacks Investment Research on MSN
LeMaitre Vascular (LMAT) tops Q1 earnings estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.48 per share a year ago. These ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results